C90 - Clinical Epilepsy I: Basics
| Event Time: | Monday May 6, 2019 1:00 pm to 3:00 pm |
| Topic(s): | Epilepsy/Clinical Neurophysiology (EEG), Foundations in Clinical Neurology for APPs |
| Director(s): | Tracey Milligan MD, FAAN |
| Description: | Faculty will comprehensively cover aspects of diagnosing and managing patients with seizure disorders; review the 2017 ILAE classification scheme, Epilepsy Quality Measures, and the primary goals of accurate diagnosis and selection of appropriate first-line medications; address common psychiatric comorbidities; review the latest advances in each topic discussed; and use video case presentations to illustrate the differential diagnosis of seizure-like events and how to classify seizures. This program complements Clinical Epilepsy II: Considerations Across the Age Span: Pediatrics, Pregnancy, and Elderly, Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG), and Clinical Epilepsy IV: Surgery, but covers independent topics. |
| Completion Message: | Participants should be able to efficiently and thoroughly evaluate a patient presenting with seizures, accurately apply the latest approved classification system for epilepsy, choose appropriate first-line treatments, and recognize and know how to evaluate common psychiatric comorbidities. |
| CME Credits: | 2 |
| Core Competencies: | Patient Care, Medical Knowledge |
| Start/End Time | Title | Faculty |
|---|---|---|
| 1:00 PM - 1:35 PM | Video Cases in Diagnosis and Classification | Tracey A. Milligan MD, FAAN |
| 1:35 PM - 2:05 PM | Psychiatric Co-morbidities: What All Neurologists Need to Know in the Management of Epilepsy | Andres M. Kanner MD, FAAN |
| 2:05 PM - 2:45 PM | Individualizing AED Choices | Jacqueline French MD, FAAN |
| Speaker | Disclosure |
|---|---|
| Jacqueline French, MD, FAAN | Dr French did not receive personal income, but received NYU salary support from the Epilepsy Foundation and for consulting work and/or attending Scientific Advisory Boards on behalf of the Epilepsy Study Consortium for Acadia, Adamas, Addex, Aeonian, Alexza, Anavex, Axcella Health, Axovant, Biogen, Biomotiv/Koutif, Blackfynn, Bloom Science, Bridge Valley Ventures, Cavion, Cerebral Therapeutics, Cerevel, Clinilabs, Concert Pharmaceuticals, Covance, Crossject, CuroNZ, Eisai, Empatica, Engage Therapeutics, Epitel, GW Pharma, Idorsia, Impax, Ionis, J&J Pharmaceuticals, Marinus, MonosolRx, Neurelis, Novartis, Otsuka Pharmaceutical Development, Ovid Therapeutics Inc., Pfizer, Pfizer-Neusentis, Praxis, Redpin, Sage, Sancillio, Shire, SK Life Sciences, Springworks, Stoke, Sunovion, Supernus, Takeda, UCB Inc., Ultragenyx, Upsher Smith, Vyera, West Therapeutic Development, Xenon, Xeris, Zogenix, Zynerba. Dr. French received research grants from Biogen, Cavion, Engage, Neurelis, Ovid, SK Life Sciences, UCB, and Zogenix. |
| Andres M. Kanner, MD, FAAN | Dr. Kanner has nothing to disclose. |
| Tracey A. Milligan, MD, FAAN | Dr. Milligan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen. |
Ready to register for the 2019 AAN Annual Meeting?
Related Courses
| 7:00 AM-9:00 AM |
|---|
|
C244 -
Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases
Matthew Hoerth MD |
|
C247 -
What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders
Stephanie Nahas MD, FAAN |
| 1:00 PM-3:00 PM |
|
C250 -
Update in Epilepsy
Joseph Sirven MD, FAAN |